Investing.com -- Apple (NASDAQ:AAPL) is stepping into the realm of brain-computer interfaces (BCIs), a move that could potentially change the way we interact with our devices. The tech giant is ...

Cognixion, a developer of noninvasive brain-computer interface technology, has launched a clinical study that integrates its EEG-based brain-computer interface with Apple Vision Pro. The study aims to ...

A new brain implant now lets people control Apple devices, such as iPads, iPhones and the Vision Pro, using only their thoughts. Synchron, an endovascular brain-computer interface (BCI) company based ...

California-based Cognixion is launching a clinical trial to allow paralyzed patients with speech disorders the ability to communicate without an invasive brain implant. Cognixion is one of several ...

Apple has partnered with neurotechnology company Synchron to develop products including iPhones and iPads that will be controlled using brain implants. Designed to allow users with physical ...

Apple has recently secured a patent for a neural interface technology that promises to revolutionize how users interact with their devices. By leveraging brain-computer interface (BCI) technology, ...

Apple is adding support for brain-computer interfaces (BCIs) to iOS, iPadOS, and visionOS, and Brooklyn-based Synchron is among the first to test it on patients. BCIs are "an emerging technology that ...

Elon Musk has announced that Neuralink plans to begin high-volume production of its brain-computer interface devices in 2026, ...